Akèy › Metiyè › Bioengineers and Biomedical Engineers › Milpitas, CA
Bioengineers and Biomedical Engineers nan Milpitas, CA: Salè H-1B
22 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Milpitas, CA. Salè baz medyàn ofri $125,694; mwatye mitan $105,269–$146,576.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $105,269 |
| Nivo II (kalifye) | $105,600 |
| Nivo III (eksperyans) | $146,250 |
| Nivo IV (plen kompetans) | $150,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Becton, Dickinson and Company | 7 | $145,000 |
| Stellartech Research Corporation | 3 | $95,000 |
| N1 Life Inc | 2 | $118,800 |
| Topcon Healthcare Inc. | 2 | $131,750 |
| Augusta Life Sciences US OpCo I LLC | 2 | $127,634 |
| Bigfoot Biomedical, Inc. | 1 | $146,576 |
| Elixir Medical Corporation | 1 | $75,275 |
| VitroLabs Inc. | 1 | $96,000 |
| OBiO Tech, Inc. | 1 | — |
| Galaxy Therapeutics Inc | 1 | $105,000 |
| Tiposi | 1 | $125,694 |
Tit travay
- Quality Engineer2
- Staff Quality Engineer2
- Senior Systems Design Assurance Engineer1
- Quality Assurance Engineer I1
- R&D Engineer1
- Research Scientist1
- Research Associate1
- Process Development Engineer II1
- Engineering Project Manager, Program Management1
- Staff Engineer I, Systems Verification1
- Senior Application Scientist1
- Research and Development Engineer1
- Research Scientist, Image Processing R&D1
- Senior I, Systems Verification Scientist1
- Senior Global Service Engineer1
Pwonse H-1B nan Milpitas, CA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).